On September 3, 2021 RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases, reported that Brian Wong, M.D., Ph.D., President and CEO, will present at the following investor conferences in the first half of September (Press release, RAPT Therapeutics, SEP 3, 2021, https://investors.rapt.com/news-releases/news-release-details/rapt-therapeutics-present-upcoming-investor-conferences [SID1234587235]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Wells Fargo 2021 Virtual Healthcare Conference Thursday, September 9, 2021 at 8:00 a.m. EST
H.C. Wainwright 23rd Annual Global Investment Conference presentation available on-demand Monday, September 13, 2021 at 7:00 a.m. EST
To access the live webcasts or subsequent archived recordings of the company presentations, please visit the RAPT Therapeutics website at https://investors.rapt.com/events-and-presentations.